A case report of immunotherapy-related breast reactive capillary endothelial proliferation
Reactive capillary endothelial proliferation (RCEP) is the most common immune-related adverse event (irAE) during Camrelizumab treatment. RCEP occurs in the majority of patients with advanced solid tumors who receive Camrelizumab monotherapy. This irAE mainly occurs in the skin clinically, and RCEP...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Chinês |
| Vydáno: |
Editorial Office of New Medicine
2023-02-01
|
| Edice: | Yixue xinzhi zazhi |
| Témata: | |
| On-line přístup: | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2302/XxOqFquz1qmFfjHsPR3gIrZjMjcRug5Zp5O0CZd7.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
